Literature DB >> 3021645

The role of renal prostaglandin E as a possible modulator of cyclic AMP production in nephrotic syndrome.

S Túri, Z Havass, T Bodrogi.   

Abstract

Urinary prostaglandin E (PGE) and cyclic AMP (cAMP) excretions were studied by radioimmunoassay in children with nephrotic syndrome and in a control population. In cases with nephrotic syndrome there was a significant elevation in urinary PGE excretion and cAMP excretion was decreased. A positive correlation was found between urinary cAMP excretion and urinary osmolality (Uosm) and the ratio urine to plasma osmolality (Uosm/Posm); and a negative correlation between urinary cAMP excretion and urine volume. A negative correlation was observed between the values of PGE excretion and urinary cAMP. These data confirmed the role of PGE as a modulator of cAMP production, which was inhibited in the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021645     DOI: 10.1007/bf02082721

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion.

Authors:  R J Anderson; T Berl; K M McDonald; R W Schrier
Journal:  Kidney Int       Date:  1976-09       Impact factor: 10.612

Review 2.  Prostaglandins, potassium, and Bartter's syndrome.

Authors:  T F Ferris
Journal:  J Lab Clin Med       Date:  1978-11

3.  Renal water handling in minimal change nephrotic syndrome.

Authors:  A B Bohlin; U Berg
Journal:  Int J Pediatr Nephrol       Date:  1984-06

4.  A study of the renal handling of water in lipoid nephrosis.

Authors:  A Gur; P Y Adefuin; N J Siegel; J P Hayslett
Journal:  Pediatr Res       Date:  1976-03       Impact factor: 3.756

5.  Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis.

Authors:  R M Pérez-Ayuso; V Arroyo; J Camps; A Rimola; J Gaya; J Costa; F Rivera; J Rodés
Journal:  Kidney Int       Date:  1984-07       Impact factor: 10.612

6.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

7.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

8.  DDAVP test for estimation of renal concentrating capacity in infants and children.

Authors:  A S Aronson; N W Svenningsen
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

9.  Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3',5'-monophosphate, and theophylline.

Authors:  J J Grantham; J Orloff
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Renal prostaglandins in systemic lupus erythematosus.

Authors:  R P Kimberly
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.